Month: August 2021

Global rights to registrational-stage ophthalmology drug return to Molecular Partners Improvements in manufacturing and formulation have been made and tested in pre-clinical models with the potential to overcome inflammatory side effectsOngoing research discovery alliance with AbbVie in ophthalmology to continueZURICH-SCHLIEREN, Switzerland, Aug. 09, 2021 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LRMolecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced today the receipt of notification from its partner, AbbVie Inc., regarding its termination of the license and collaboration agreement for the investigational drug abicipar pegol for the treatment of neovascular age-related macular degeneration...

Innofactor Plc press release, on August 9, 2021, at 7:00 Finnish time Effective from August 9, 2021, Innofactor has appointed Jarno Limnéll, Professor of Practice, Cybersecurity at Aalto University, as head of the company’s new Cybersecurity Unit. Together with HUS Helsinki University Hospital, KPMG and Microsoft, Innofactor is organizing a virtual media event today, at 12:00 noon, on the topic of cybersecurity in Finnish organizations. Event participants will have the opportunity to ask Limnéll and other speakers questions about cybersecurity in Finland. Effective from August 9, 2021, Innofactor has appointed Jarno Limnéll, Professor of Practice, Cybersecurity at Aalto University, as head of the company’s new Cybersecurity Unit. He will join Innofactor’s Finnish leadership team and be responsible for the business of the unit that...

SANTA MONICA, Calif., Aug. 08, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders, liver disease and certain cancers, today announced the pricing of its underwritten public offering of 2,500,000 shares of its Class A common stock at a public offering price of $8.00 per share, for gross proceeds of  $20,000,000, before deducting underwriting discounts, commissions and offering expenses. In addition, the Company has granted the underwriters a 45 day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments at the offering price, less the underwriting discount. ThinkEquity, a division of Fordham Financial Management, Inc., is acting as the...

Collaboration designed to accelerate global development and investigate TAZVERIK® combinations with HUTCHMED’s novel oncology medicines portfolio Epizyme to receive US$25 million upfront payment and up to US$285 million in potential milestone payments, together with additional tiered royalties; HUTCHMED to receive development and commercial rights to TAZVERIK® in Greater China HUTCHMED to host a webcast and call on Monday August 9, at 9:30 a.m. EDT / 2:30 p.m. BST / 9:30 p.m. HKT – see www.hutch-med.com/event for details HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J. and CAMBRIDGE, Mass, Aug. 08, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) and Epizyme, Inc. (“Epizyme”) (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel...

Company Goes to Great Lengths to Prioritize Health and Safety of its Guests, Crew and the Communities Visited MIAMI, Aug. 08, 2021 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (the “Company”) (NYSE: NCLH), a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands, is pleased to report that today Judge Williams ruled in its favor granting a preliminary injunction which paves the way for the Company’s three brands to require documentation confirming a guest’s vaccination status prior to boarding. This order will now allow the Company to operate in the safest way possible with 100% vaccinationi of all guests and crew when sailing from Florida ports. Nothing takes priority over the health and safety of the Company’s guests, crew and the communities visited...

Maha is pleased to announce that Alan Johnson, member of the Management Group, assumes the role of the Company’s Chief Operating Officer (COO) effective immediately. Alan joined the Company in September of 2019 in the capacity of the Vice President of Operations, and his responsibilities will continue to support Maha as it enters this next phase of its growth plans.   MiscellaneousThe information was submitted for publication, through the agency of the contact person set out below, at 17:00 CET on 8 August, 2021. For more information, please contact:         Jonas Lindvall (CEO)Tel: +46 8 611 05 11        jonas@mahaenergy.ca Victoria Berg (Investor Relations)Tel: +46 8 611 05 11       victoria@mahaenergy.ca About MahaMaha Energy AB (publ) is a listed, international upstream oil and gas company whose business activities include exploration,...

VANCOUVER, British Columbia, Aug. 07, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that the scientific team of its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has initiated the next step in their clinical development designs for the use of their patent pending psychedelic formulations AKO001 and AKO003, in the treatment of ischemic stroke and depression, respectively. These studies will further enhance the Company’s knowledge supporting the use of psychedelics as strong candidates in the treatment of these serious neurological and mental health conditions. As the next step in its clinical development design process, Akome is completing a comprehensive search and rigorous selection process, through which multiple...

WASHINGTON, Aug. 07, 2021 (GLOBE NEWSWIRE) — ibex today issued this announcement concerning an earlier event, disclosed by the company on October 23, 2020 in its Annual Report (Form 20-F), which may have potentially impacted the security of information relating to certain employees and their families. While ibex is unaware of any attempted or actual misuse of personal information in relation to the event, ibex provided potentially affected individuals with notice, information about the event and steps individuals can take to help protect their information. On August 17, 2020, ibex learned that it was the victim of a malware attack that impacted the availability of a limited segment of our systems. We immediately took these systems offline and, with the assistance of third-party computer specialists, launched an investigation to...

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the first tranche (the “First Tranche”) of its previously announced non-brokered private placement (“Placement”) of up to $1.2 million. The Company completed the First Tranche of the Placement for total gross proceeds of $722,510 by issuing 14,450,200 Units (“Units”) at a price of $0.05 per Unit. Each Unit consists of one Common Share of the Company (each a “Common Share”, collectively, the “Common Shares”) and one common share purchase warrant (each warrant referred to herein as a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one Common Share...

CALGARY, Alberta, Aug. 06, 2021 (GLOBE NEWSWIRE) — It is with great sadness that the Board of Directors of Questor Technology Inc. (“Questor” or the “Company”), (TSX Venture Exchange: QST) announce that Jean-Michel Gires, a director, has passed away. “On behalf of the Board of Directors and management at Questor, I wish to extend my deepest condolences to Jean-Michel’s family and friends at this difficult time,” said Audrey Mascarenhas, President and CEO. Jean-Michel had been a Questor director since September 2013. He was truly a visionary leader who cared passionately about making a difference.  Jean-Michel was a tremendous supporter of the Company and his vast industry experience mixed with his passion for the environment was greatly appreciated. Mr. Gires passed away in Germany surrounded...